Rıdvan Ali

1.2k total citations
55 papers, 609 citations indexed

About

Rıdvan Ali is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Rıdvan Ali has authored 55 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 19 papers in Genetics and 14 papers in Oncology. Recurrent topics in Rıdvan Ali's work include Chronic Myeloid Leukemia Treatments (11 papers), Eosinophilic Disorders and Syndromes (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Rıdvan Ali is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Eosinophilic Disorders and Syndromes (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Rıdvan Ali collaborates with scholars based in Türkiye, Germany and Pakistan. Rıdvan Ali's co-authors include Fahir Özkalemkaş, Vildan Özkocaman, Ahmet Tunalı, Yalçın Kímya, Tülay Özçelik, Nilgün Köksal, Tahsin Yakut, Ülkü Özan, Meral Beksaç and Gülsüm Özet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Thyroid.

In The Last Decade

Rıdvan Ali

49 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rıdvan Ali Türkiye 14 348 216 165 130 129 55 609
Sabine Fürst France 16 589 1.7× 191 0.9× 75 0.5× 184 1.4× 141 1.1× 46 727
Maria Luisa Moleti Italy 16 251 0.7× 225 1.0× 125 0.8× 120 0.9× 260 2.0× 65 737
J. H. Lipton Canada 15 508 1.5× 183 0.8× 62 0.4× 242 1.9× 122 0.9× 29 808
Vaneuza Araújo Moreira Funke Brazil 14 431 1.2× 176 0.8× 120 0.7× 130 1.0× 111 0.9× 61 646
Adrienne de Labarthe France 11 636 1.8× 130 0.6× 163 1.0× 96 0.7× 315 2.4× 20 831
Carlo Castagnola Italy 16 327 0.9× 91 0.4× 132 0.8× 187 1.4× 91 0.7× 47 574
Hassan B. Alkhateeb United States 14 502 1.4× 116 0.5× 190 1.2× 222 1.7× 125 1.0× 148 743
Shuichi Mizuta Japan 18 547 1.6× 265 1.2× 58 0.4× 126 1.0× 411 3.2× 58 797
DW Beelen Germany 14 750 2.2× 178 0.8× 113 0.7× 142 1.1× 171 1.3× 18 877
Roni Tamari United States 18 601 1.7× 278 1.3× 161 1.0× 205 1.6× 127 1.0× 98 977

Countries citing papers authored by Rıdvan Ali

Since Specialization
Citations

This map shows the geographic impact of Rıdvan Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rıdvan Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rıdvan Ali more than expected).

Fields of papers citing papers by Rıdvan Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rıdvan Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rıdvan Ali. The network helps show where Rıdvan Ali may publish in the future.

Co-authorship network of co-authors of Rıdvan Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Rıdvan Ali. A scholar is included among the top collaborators of Rıdvan Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rıdvan Ali. Rıdvan Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özkocaman, Vildan, et al.. (2025). Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome. Biomolecules and Biomedicine. 25(5). 1175–1183. 1 indexed citations
2.
Özkocaman, Vildan, et al.. (2023). Potential modifications of the PLASMIC scoring system for predicting thrombotic thrombocytopenic purpura: Sometimes, less is more. International Journal of Laboratory Hematology. 45(5). 751–757. 1 indexed citations
3.
4.
Özkocaman, Vildan, et al.. (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports. 13(1). 12539–12539. 8 indexed citations
5.
Kazak, Esra, Vildan Özkocaman, Ahmet Ursavaş, et al.. (2023). Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience. European Journal of Clinical Microbiology & Infectious Diseases. 43(1). 33–43. 3 indexed citations
6.
Saydam, Güray, Rıdvan Ali, Ahmet Muzaffer Demir, et al.. (2022). The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia. PubMed. 11(1). IJH38–IJH38. 11 indexed citations
7.
Özkalemkaş, Fahir, et al.. (2022). THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES. Mediterranean Journal of Hematology and Infectious Diseases. 14(1). e2022051–e2022051. 4 indexed citations
8.
Özkocaman, Vildan, et al.. (2021). HIV Related Primary Central Nervous System Lymphoma: Case Study. SHILAP Revista de lepidopterología. 3(Supplement 1). 77–78.
9.
Özkalemkaş, Fahir, Vildan Özkocaman, Beyza Ener, et al.. (2021). Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies. Cureus. 13(7). e16445–e16445. 9 indexed citations
10.
Ersoy, Alparslan, et al.. (2020). Granulocyte colony-stimulating factor usage in drug-induced neutropenia after kidney transplantation: a single-center experience. SHILAP Revista de lepidopterología. 2(1). 11–18. 1 indexed citations
11.
Ali, Rıdvan, et al.. (2016). Antifosfolipid Antikor Sendromu. 9(4). 44–48.
12.
Yakut, Tahsin, et al.. (2015). Qualitative and Quantitative Evaluation of the BCR-ABL Fusion Gene in Chronic Myelogenous Leukemia by Flourescence In Situ Hybridization and Molecular Genetic Methods. Genetic Testing and Molecular Biomarkers. 19(10). 584–588. 4 indexed citations
13.
Türe, Mehmet, et al.. (2015). Association of the ACE I/D Gene Polymorphisms with JAK2V617F- Positive Polycythemia Vera and Essential Thrombocythemia. Genetic Testing and Molecular Biomarkers. 19(6). 303–308. 3 indexed citations
14.
Dizdar, Oğuzhan Sıtkı, Faruk Karakeçili, Belkıs Nihan Coşkun, et al.. (2012). Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012039–e2012039. 4 indexed citations
15.
16.
Özkan, Hilal, Merih Çetınkaya, Nilgün Köksal, et al.. (2009). Neonatal outcomes of pregnancy complicated by idiopathic thrombocytopenic purpura. Journal of Perinatology. 30(1). 38–44. 21 indexed citations
17.
18.
Ali, Rıdvan, et al.. (2007). Acute myeloblastic leukaemia (AML‐M1) presenting with prominent gingival hypertrophy. European Journal Of Haematology. 78(6). 547–547. 2 indexed citations
19.
Ali, Rıdvan, et al.. (2003). Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes. Annals of Hematology. 82(6). 348–352. 18 indexed citations
20.
Ali, Rıdvan, et al.. (2001). Management trend and safety of vaginal delivery for term breech fetuses in a tertiary care hospital of Karachi, Pakistan. Journal of Perinatal Medicine. 29(3). 250–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Fürst Breakdown of academic impact, for papers by Maria Luisa Moleti Breakdown of academic impact, for papers by J. H. Lipton Breakdown of academic impact, for papers by Vaneuza Araújo Moreira Funke Breakdown of academic impact, for papers by Adrienne de Labarthe Breakdown of academic impact, for papers by Carlo Castagnola Breakdown of academic impact, for papers by Hassan B. Alkhateeb Breakdown of academic impact, for papers by Shuichi Mizuta Breakdown of academic impact, for papers by DW Beelen Breakdown of academic impact, for papers by Roni Tamari
Rankless by CCL
2026